Application of functional quantum dots in cancer diagnosis and therapy: A review

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 29, Issue 1, 2013, Pages 10-20

  Han, Shuang ^a   Xia, Tian ^a   Li, Qingning ^a   Guo, Junming ^a   Lu, Peibei ^b  

^a NINGBO UNIVERSITY   (China)

^b Ningbo College of Health Sciences   (China)

Author keywords

Early diagnosis of tumor; Nanotechnology; Quantum dots (QDs); Toxicity; Tumor therapy

Indexed keywords

DIAGNOSTIC AGENT; NANOPARTICLE; QUANTUM DOT;

ANIMAL; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; HUMAN; METHODOLOGY; NANOMEDICINE; NEOPLASM; REVIEW;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; QUANTUM DOTS;

EID: 84874977485     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Shao L, Gao Y, Yan F. Semiconductor quantum dots for biomedicial applications. Sensors, 2011, 11(12): 11736-11751.
2. Li J, Li M, Tang J, et al. Resonance light-scattering spectrometric study of interaction between enzyme and MPA-modified CdTe nanoparticles. Spectrochim Acta A Mol Biomol Spectrosc, 2008, 70(3): 514-518.
3. Xiao JB, Chen TT, Chen LS, et al. CdTe quantum dots (QDs) improve the affinities of baicalein and genistein for human serum albumin in vitro. J Inorg Biochem, 2010, 104(11): 1148-1155.
4. Liu L, Zhang J, Su X, et al. In vitro and In vivo assessment of CdTe and CdHgTe toxicity and clearance. J Biomed Nanotechnol, 2008, 4(4): 524-528.
5. Choi SJ, Oh JM, Choy JH. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem, 2009, 103(3): 463-471.
6. Su HP, Xu HY, Gao S, et al. Microwave synthesis of nearly monodisperse core/multishell quantum dots with cell imaging applications. Nanoscale Res Lett, 2010, 5(3): 625-630.
7. Sun DP, Yang K, Zheng G, et al. Study on effect of peptide-conjugated near-infrared fluorescent quantum dots on the clone formation, proliferation, apoptosis, and tumorigenicity ability of human buccal squamous cell carcinoma cell line BcaCD885. Int J Nanomedicine, 2010, 5: 401-405.
8. Shi DL, Bedford NM, Cho HS. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics. Small, 2011, 7(18): 2549-2567.
9. Giljohann DA, Mirkin CA. Drivers of biodiagnostic development. Nature, 2009, 462(7272): 461-464.
10. Zeng QH, Zhang YL, Liu XM, et al. Multiple homogeneous immunoassays based on a quantum dots-gold nanorods FRET nanoplatform. Chem Commun (Camb), 2012, 48(12): 1781-1783.
11. Chen C, Sun SR, Gong YP, et al. Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2. Biomaterials, 2011, 32(30): 7592-7599.
12. Jang EJ, Kim SY, Koh WG. Microfluidic bioassay system based on microarrays of hydrogel sensing elements entrapping quantum dot-enzyme conjugates. Biosens Bioelectron, 2012, 31(1): 529-536.
13. Smith AM, Duan H, Mohs AM, et al. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev, 2008, 60(11): 1226-1240.
14. Jokerst JV, Raamanathan A, Christodoulides N, et al. Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosens Bioelectron, 2009, 24(12): 3622-3629.
15. Gérard VA, Maguire CM, Bazou D, et al. Folic acid modified gelatine coated quantum dots as potential reagents for in vitro cancer diagnostics. J Nanobiotechnol, 2011, 9: 50-56.
16. Chen AK, Behlke MA, Tsourkas A. Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells. Nucleic Acids Research, 2007, 35(16): 1-12.
17. Yezhelyev MV, Qi LF, O'Regan RM, et al. Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc, 2008, 130(28): 9006-9012.
18. Subramaniam P, Lee SJ, Shah S, et al. Generation of a library of non-toxic quantum dots for cellular imaging and siRNA delivery. Adv Mater, 2012, 24(29): 4014-4019.
19. Sun J, Zhu MQ, Fu K, et al. Lead sulfide near-infrared quantum dot bioconjugates for targeted molecular imaging. Int J Nanomedicine, 2007, 2(2): 235-240.
20. Tiwari DK, Jin T, Behari J. Bio-distribution and toxicity assessment of intravenously injected anti-HER2 antibody conjugated CdSe/ZnS quantum dots in Wistar rats. Int J Nanomedicine, 2011, 6: 463-475.
21. Ghasemi Y, Peymani P, Afifi S.Quantum dot: magic nanoparticle for imaging, detection and targeting. Acta Biomed, 2009, 80(2): 156-165.
22. Liu XL, Peng CW, Chen C, et al. Quantum dots-based double-color imaging of HER2 positive breast cancer invasion. Biochem Biophys Res Commun, 2011, 409(3): 577-582.
23. Cheruvathoor PA, Veeranarayanan S, Mohamed MS, et al. PEG coated biocompatible cadmium chalcogenide quantum dots for targeted imaging of cancer cells. J Fluoresc, 2012, 22(3): 931-944.
24. Diagaradjane P, Orenstein-Cardona JM, Colon-Casasnovas NE, et al. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res, 2008, 14(3): 731-741.
25. Leung K. Molecular Imaging and Contrast Agent Database. Bethesda: National Center for Biotechnology Information Press, 2007: 2004-2011.
26. Kim TH, El-Said WA, Choi JW. Highly sensitive electrochemical detection of potential cytotoxicity of CdSe/ZnS quantum dots using neural cell chip. Biosens Bioelectron, 2012, 32(1): 266-272
27. Shi CM, Zhu Y, Xie ZH, et al. Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots. Urology, 2009, 74(2): 446-451.
28. Cai W, Chen K, Li ZB, et al. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med, 2007, 48(11): 1862-1870.
29. Kantelhardt SR, Caarls W, de Vries AH, et al. Specific visualization of glioma cells in living low-grade tumor tissue. PLoS ONE, 2010, 5(6): e11323.
30. 4/CdTe magnetic/fluorescent nanocomposites and their applications in immuno-labeling and fluorescent imaging of cancer cells. Langmuir, 2010, 26(2): 1278-1284.
31. Song EQ, Zhang ZL, Luo QY, et al. Tumor cell targeting using folate-conjugated fluorescent quantum dots and receptor-mediated endocytosis. Clin Chem, 2009, 55(5): 955-963.
32. Yang K, Zhao C, Cao YA, et al. In vivo and in situ imaging of head and neck squamous cell carcinoma using near-infrared fluorescent quantum dot probes conjugated with epidermal growth factor receptor monoclonal antibodies in mice. Oncol Rep, 2012, 27(6): 1925-1931.
33. Steponkiene S, Kavaliauskiene S, Purviniene R, et al. Quantum dots affect expression of CD133 surface antigen in melanoma cells. Int J Nanomedicine, 2011, 6: 2437-2444.
34. Kim MJ, Lee JY, Nehrbass U, et al. Detection of melanoma using antibody-conjugated quantum dots in a coculture model for high-throughput screening system. Analyst, 2012, 137(6): 1440-1445.
35. Erogbogbo F, Yong KT, Roy I, et al. Biocompatible luminescent silicon quantum dots for imaging of cancer cells. ACS Nano, 2008, 2(5): 873-878.
36. Zaman MB, Baral TN, Jakubek ZJ, et al. Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer. J Nanosci Nanotechnol, 2011, 11(5): 3757-3763.
37. Xiang Y, Zhang YY, Chang YQ, et al. Reverse-micelle synthesis of electrochemically encoded quantum dot barcodes: application to electronic coding of a cancer marker. Anal Chem, 2010, 82(3): 1138-1141.
38. Liu YS, Sun Y, Vernier PT, et al. pH-sensitive photoluminescence of CdSe/ZnSe/ZnS quantum dots in human ovarian cancer cells. J Phys Chem C Nanomater Interfaces, 2007, 111(7): 2872-2878.
39. Liu J, Lau SK, Varma VA, et al. Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano, 2010, 4(5): 2755-2765.
40. Zhang H, Zeng X, Li Q, et al. Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore. Br J Cancer, 2009, 101(1): 71-79.
41. Parungo CP, Colson YL, Kim SW, et al. Sentinel lymph node mapping of the pleural space. Chest, 2005, 127(5): 1799-1804.
42. Frangioni JV, Kim SW, Ohnishi S, et al. Sentinel lymph node mapping with type-II quantum dots. Methods Mol Biol, 2007, 374: 147-159.
43. Soltesz EG, Kim S, Laurence RG, et al. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg, 2005, 79(1): 269-277.
44. Robe A, Pic E, Lassalle HP, et al. Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice. BMC Cancer, 2008, 8:111-120.
45. Zhang G, Shi LX, Selke M, et al. CdTe quantum dots with daunorubicin induce apoptosis of multidrug-resistant human hepatoma HepG2/ADM cells: in vitro and in vivo evaluation. Nanoscale Res Lett, 2011, 6(1): 418-425.
46. Zhang Y, So MK, Rao JH. Protease-modulated cellular uptake of quantum dots. Nano Lett, 2006, 6(9): 1988-1992.
47. Yoo JH, Kim JS. Identification of p53 gene by using CdSe/ZnS conjugation and hybridization. J Nanosci Nanotechnol, 2011, 11(5): 4343-4346.
48. Muthu MS, Kulkarni SA, Raju A, et al. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials, 2012, 33(12): 3494-3501.
49. Xu WM, Liu LZ, Brown NJ, et al. Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice. Molecules, 2012, 17(1): 796-808.
50. Luo GP, Long J, Zhang B, et al. Quantum dots in cancer therapy. Expert Opin Drug Deliv, 2012, 9(1): 47-58.
51. Choi AO, Cho SJ, Desbarats J, et al. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnol, 2007, 5(1): 1-13.
52. Ambrosone A, Mattera L, Marchesano V, et al. Mechanisms underlying toxicity induced by CdTe quantum dots determined in an invertebrate model organism. Biomaterials, 2012, 33(7): 1991-2000.
53. Chen N, He Y, Su YY, et al. The cytotoxicity of cadmium-based quantum dots. Biomaterials, 2012, 33(5): 1238-1244.
54. Xiao Y, Forry SP, Gao X, et al. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake. J Nanobiotechnol, 2010, 8: 13-21.
55. Rosenthal SJ, Chang JC, Kovtun O, et al. Biocompatible quantum dots for biological applications. Chem Biol, 2011, 18(1): 10-24.
56. Gorelikov I, Martin AL, Seo M, et al. Silica-coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells. Langmuir, 2011, 27(24): 15024-15033.
57. Gao J, Chen K, Xie R, et al. Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small, 2010, 6(2): 256-261.
58. Zheng H, Chen GC, Song FM, et al. The cytotoxicity of OPA-modified CdSe/ZnS core/shell quantum dots and its modulation by silibinin in human skin cells. J Biomed Nanotechnol, 2011, 7(5): 648-658.
59. Zhang W, He XW, Chen Y, et al. Molecularly imprinted polymer anchored on the surface of denatured bovine serum albumin modified CdTe quantum dots as fluorescent artificial receptor for recognition of target protein. Biosens Bioelectron, 2012, 31(1): 84-89.
60. Zrazhevskiy P, Gao XH. Multifunctional quantum dots for personalized medicine. Nano Today, 2009, 4(5): 414-428.